We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Enrollment Mistake May Delay Approval of Asthma Drug
Enrollment Mistake May Delay Approval of Asthma Drug
February 4, 2009
Some of the patients in a Phase III clinical trial of a new asthma inhaler were assigned to the wrong study arm by the CRO running the study, causing SkyePharma a possible delay of a few months in filing its European marketing authorization application.